BIODESIX INC 10-Q filing
Filed 2025-11-03 · Report date 2025-09-30 · 2025
Filing metadata
- Accession number
- 0001193125-25-262532
- Form type
- 10-Q
- CIK
- 0001439725
- Primary document
- https://www.sec.gov/Archives/edgar/data/1439725/000119312525262532/bdsx-20250930.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for BIODESIX INC.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $59.7M | - | - |
| Operating Income | $-25.9M | - | - |
| Net Income | $-31.3M | - | - |
| Eps Basic | -4.24 | - | - |
| Eps Diluted | -4.24 | - | - |
| Cash And Equivalents | $16.6M | - | - |
| Total Assets | $88.7M | - | - |
| Total Liabilities | $90.4M | - | - |
| Shareholders Equity | $-1.7M | - | - |
| Operating Cash Flow | $-24.0M | - | - |
| Capital Expenditures | $173,000 | - | - |